Paper21775111
Impact of overweight and obesity on cardiac benefit of antihypertensive treatment.
Gerdts E and 8 others. Nutr Metab Cardiovasc Dis, 2013. Cited by 28 papers, by iCite.
Cite this record
ConductScience Library. Impact of overweight and obesity on cardiac benefit of antihypertensive treatment. Papers, record 21775111. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21775111
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antihypertensive Agents | Major topic |
| Hypertension | Major topic |
| Obesity | Major topic |
| Overweight | Major topic |
| Aged | |
| Aged, 80 and over | |
| Blood Pressure | |
| Body Mass Index | |
| Body Weight | |
| Double-Blind Method | |
| Echocardiography | |
| Endpoint Determination | |
| Female | |
| Humans | |
| Hypertrophy, Left Ventricular | |
| Losartan | |
| Male | |
| Middle Aged | |
| Myocardial Infarction | |
| Stroke | |
| Treatment Outcome |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40630433 | An Exploration of the Relationship Between Gut Virome and Cardiovascular Disease: A Comprehensive Review. | Rev Cardiovasc Med | 2025 | https://conductscience.org/library/papers/40630433 | PubMed |
| 33949876 | Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications. | Physiol Rev | 2021 | https://conductscience.org/library/papers/33949876 | PubMed |
| 32389356 | Adiposity, Sex, and Cardiovascular Disease Risk in Children With CKD: A Longitudinal Study of Youth Enrolled in the Chronic Kidney Disease in Children (CKiD) Study. | Am J Kidney Dis | 2020 | https://conductscience.org/library/papers/32389356 | PubMed |
| 29931482 | Discrepancies Between BMI and Classic Cardiovascular Risk Factors. | Obes Surg | 2018 | https://conductscience.org/library/papers/29931482 | PubMed |
| 26700209 | The Role of Obesity in the Development of Left Ventricular Hypertrophy Among Children and Adolescents. | Curr Hypertens Rep | 2016 | https://conductscience.org/library/papers/26700209 | PubMed |
| 25794954 | Obesity and left ventricular hypertrophy: the hypertension connection. | Curr Hypertens Rep | 2015 | https://conductscience.org/library/papers/25794954 | PubMed |
| 25117210 | Left ventricular hypertrophy and obesity: only a matter of fat? | High Blood Press Cardiovasc Prev | 2015 | https://conductscience.org/library/papers/25117210 | PubMed |
| 23744404 | Lack of reduction of left ventricular mass in treated hypertension: the strong heart study. | J Am Heart Assoc | 2013 | https://conductscience.org/library/papers/23744404 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21775111
GET https://conductscience.org/api/papers/v1/21775111/authors